Overall rank by patents
#38,757
Across all tracked assignees
USPTO PatentsView assignee record - 6 granted patents across 2 technology areas, active 2018–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B01F (MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING).
The verdict
Aarke holds 6 US patents across 2 technology areas, rank #38,757 of 50,000 tracked assignees.
Aarke AB has been granted 6 US utility patents between 2018 and 2025, placing Aarke AB at rank #38,757 across all assignees tracked by PlainPatent. This portfolio spans 2 distinct Cooperative Patent Classification (CPC) subclasses, averaging 5.7 claims per patent with primary concentration in B01F (MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING). As a Foreign Corporation, Aarke AB is one of the more focused assignees in the PatentsView dataset. By volume, Aarke sits between AXON VIBE Ag (6 patents, rank #38,753) and Academic Pharmcauticals, Inc. (6 patents, rank #38,761) - the closest US assignees by grant volume. The composite Innovation Score of 28.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 5 grants, compared with 1 in the 2015–2019 window, a +400% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Aarke AB's 5.7 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while specialization in 2 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Aarke AB against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
AXON VIBE AG
6 patents
AXT, INC.
6 patents
AXXANA (ISRAEL) LTD.
6 patents
AZITRA INC.
6 patents
Abela Pharmaceuticals, Inc.
6 patents
Abon Biopharm (Hangzhou) Co., Ltd.
6 patents
Acacia Technology, Inc.
6 patents
Academic Pharmcauticals, Inc.
6 patents
Aarke AB
6 patents
What this shows Aarke holds 6 patents at rank #38,757, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #38,757 in granted patent volume.
Other assignees with the most granted patents in Aarke's primary technology class.
Aarke's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
28 Top 73% higher than 27% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 1 | 16.7% |
| 2024 | 2 | 33.3% |
| 2025 | 3 | 50.0% |
Top 2 of 2 technology areas
Overall rank by patents
#38,757
Across all tracked assignees
28.5 out of 100
How to use this portfolio
Aarke's 6 grants land it in the top 73% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.